Schroder Investment Management Group Biogen Inc. Transaction History

Schroder Investment Management Group

$87.8 Billion
Q2 2024

A detailed history of Schroder Investment Management Group transactions in Biogen Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 35,980 shares of BIIB stock, worth $6.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,980

Previous 79,489 54.74%

Holding current value

$6.25 Million

Previous $17.1 Million 51.34%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $8.29 Million - $10.3 Million	-43,509 Reduced 54.74%	35,980 $8.34 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $2.79 Million - $3.52 Million	-13,142 Reduced 14.19%	79,489 $17.1 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $8.45 Million - $10.2 Million	37,948 Added 69.4%	92,631 $24 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $5.39 Million - $6.08 Million	-21,277 Reduced 28.01%	54,683 $14.1 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $520,497 - $601,451	1,891 Added 2.55%	75,960 $21.6 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $14.5 Million - $16.5 Million	56,560 Added 323.03%	74,069 $20.6 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $80,780 - $98,150	320 Added 1.86%	17,509 $4.85 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $79,628 - $109,800	-409 Reduced 2.32%	17,189 $4.59 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $545,553 - $648,765	2,909 Added 19.8%	17,598 $3.61 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $956,254 - $1.2 Million	4,935 Added 50.59%	14,689 $3.1 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $223,248 - $286,906	-997 Reduced 9.27%	9,754 $2.34 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $604,183 - $787,921	-2,135 Reduced 16.57%	10,751 $3.04 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $1.02 Million - $1.64 Million	-3,946 Reduced 23.44%	12,886 $4.46 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $63.8 Million - $74.8 Million	-262,776 Reduced 93.98%	16,832 $4.71 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $38.5 Million - $57.9 Million	-162,832 Reduced 36.8%	279,608 $68.5 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $42.5 Million - $49.1 Million	-160,597 Reduced 26.63%	442,440 $123 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $23.1 Million - $30.6 Million	89,405 Added 17.41%	603,037 $161 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $7.4 Million - $9.39 Million	27,523 Added 5.66%	513,632 $160 Million
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $2.45 Million - $3.39 Million	-11,142 Reduced 2.24%	486,109 $144 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $10.8 Million - $12.1 Million	49,701 Added 11.11%	497,251 $114 Million
Q2 2019 Aug 08, 2019	BUY	$219.29 - $241.72 $11.8 Million - $13 Million	53,605 Added 13.61%	447,550 $105 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $4.88 Million - $7.64 Million	-22,535 Reduced 5.41%	393,945 $93.1 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $18.1 Million - $23 Million	-65,125 Reduced 13.52%	416,480 $125 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $58.8 Million - $76.9 Million	-200,272 Reduced 29.37%	481,605 $170 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $57.3 Million - $68.3 Million	-222,389 Reduced 24.59%	681,877 $197 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $28.2 Million - $39.8 Million	108,297 Added 13.61%	904,266 $248 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $92.4 Million - $104 Million	300,498 Added 60.65%	795,969 $254 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $139 Million - $163 Million	495,471	495,471 $154 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Biogen Inc. Transaction History